251 related articles for article (PubMed ID: 17976100)
21. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation.
Gasparini M; Auricchio A; Regoli F; Fantoni C; Kawabata M; Galimberti P; Pini D; Ceriotti C; Gronda E; Klersy C; Fratini S; Klein HH
J Am Coll Cardiol; 2006 Aug; 48(4):734-43. PubMed ID: 16904542
[TBL] [Abstract][Full Text] [Related]
22. Long-term follow-up of cardiac resynchronization therapy in patients with end-stage heart failure.
Molhoek SG; Bax JJ; Bleeker GB; Holman ER; Van Erven L; Bootsma M; Boersma E; Steendijk P; Van Der Wall EE; Schalij MJ
J Cardiovasc Electrophysiol; 2005 Jul; 16(7):701-7. PubMed ID: 16050826
[TBL] [Abstract][Full Text] [Related]
23. Time course of effects of cardiac resynchronization therapy in chronic heart failure: benefits in patients with preserved exercise capacity.
Piepoli MF; Villani GQ; Corrà U; Aschieri D; Rusticali G
Pacing Clin Electrophysiol; 2008 Jun; 31(6):701-8. PubMed ID: 18507542
[TBL] [Abstract][Full Text] [Related]
24. Relationship between New York Heart Association class change and ventricular tachyarrhythmia occurrence in patients treated with cardiac resynchronization plus defibrillator.
Lepillier A; Piot O; Gerritse B; Copie X; Lavergne T; Paziaud O; Lascault G; Waintraub X; Otmani A; Le Heuzey JY
Europace; 2009 Jan; 11(1):80-5. PubMed ID: 18952828
[TBL] [Abstract][Full Text] [Related]
25. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR
J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
[TBL] [Abstract][Full Text] [Related]
26. Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials.
Pires LA; Abraham WT; Young JB; Johnson KM;
Am Heart J; 2006 Apr; 151(4):837-43. PubMed ID: 16569543
[TBL] [Abstract][Full Text] [Related]
27. Cardiac resynchronisation therapy in patients with end-stage heart failure--long-term follow-up.
Faran A; Lewicka-Nowak E; Dabrowska-Kugacka A; Kempa M; Tybura S; Szwoch M; Królak T; Raczak G
Kardiol Pol; 2008 Jan; 66(1):19-26; discussion 27. PubMed ID: 18266184
[TBL] [Abstract][Full Text] [Related]
28. The impact of myocardial viability on the clinical outcome of cardiac resynchronization therapy.
Riedlbauchová L; Brunken R; Jaber WA; Popová L; Patel D; Lánská V; Civello K; Cummings J; Burkhardt JD; Saliba W; Martin D; Schweikert R; Wilkoff BL; Grimm R; Natale A
J Cardiovasc Electrophysiol; 2009 Jan; 20(1):50-7. PubMed ID: 18803571
[TBL] [Abstract][Full Text] [Related]
29. A novel method of multisite atrial pacing, incorporating Bachmann's bundle area and coronary sinus ostium, for electrical atrial resynchronization in patients with recurrent atrial fibrillation.
Lewicka-Nowak E; Kutarski A; Dabrowska-Kugacka A; Rucinski P; Zagozdzon P; Raczak G
Europace; 2007 Sep; 9(9):805-11. PubMed ID: 17670780
[TBL] [Abstract][Full Text] [Related]
30. Cardiac contractility modulation in non-responders to cardiac resynchronization therapy.
Nägele H; Behrens S; Eisermann C
Europace; 2008 Dec; 10(12):1375-80. PubMed ID: 18776196
[TBL] [Abstract][Full Text] [Related]
31. Radiofrequency ablation of drug-refractory atrial fibrillation: an observational study comparing 'ablate and pace' with pulmonary vein isolation.
Proclemer A; Allocca G; Gregori D; Bonanno C; Ometto R; Fontanelli A; Mantovan R; Crosato M; Calzolari V; Pavoni D; Facchin D; Rebellato L; Fioretti PM
Europace; 2008 Sep; 10(9):1085-90. PubMed ID: 18667447
[TBL] [Abstract][Full Text] [Related]
32. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
[TBL] [Abstract][Full Text] [Related]
33. Long-term effects of cardiac resynchronization therapy in octogenarians: a comparative study with a younger population.
Foley PW; Chalil S; Khadjooi K; Smith RE; Frenneaux MP; Leyva F
Europace; 2008 Nov; 10(11):1302-7. PubMed ID: 18827063
[TBL] [Abstract][Full Text] [Related]
34. Mid-term outcomes of triple-site vs. conventional cardiac resynchronization therapy: a preliminary study.
Lenarczyk R; Kowalski O; Kukulski T; Pruszkowska-Skrzep P; Sokal A; Szulik M; Zielińska T; Kowalczyk J; Pluta S; Sredniawa B; Musialik-Łydka A; Kalarus Z
Int J Cardiol; 2009 Mar; 133(1):87-94. PubMed ID: 18242737
[TBL] [Abstract][Full Text] [Related]
35. Long-term effects of upgrading from right ventricular pacing to cardiac resynchronization therapy in patients with heart failure.
Foley PW; Muhyaldeen SA; Chalil S; Smith RE; Sanderson JE; Leyva F
Europace; 2009 Apr; 11(4):495-501. PubMed ID: 19307283
[TBL] [Abstract][Full Text] [Related]
36. Decrease of plasma N-terminal pro beta-type natriuretic peptide as a predictor of clinical improvement after cardiac resynchronization therapy for heart failure.
Ding LG; Hua W; Zhang S; Chu JM; Chen KP; Wang Y; Wang FZ; Chen X
Chin Med J (Engl); 2009 Mar; 122(6):617-21. PubMed ID: 19323922
[TBL] [Abstract][Full Text] [Related]
37. Hemodynamics and prognosis after primary cardiac resynchronization system implantation compared to "upgrade" procedures.
Nägele H; Dodeck J; Behrens S; Azizi M; Hashagen S; Eisermann C; Castel MA
Pacing Clin Electrophysiol; 2008 Oct; 31(10):1265-71. PubMed ID: 18811806
[TBL] [Abstract][Full Text] [Related]
38. Functional behavior of patients with conventional pacemakers undergoing cardiac resynchronization.
Silva RT; Martinelli Filho M; Lima CE; Martins DG; Nishióka SA; Pedrosa AA; Crevelari ES; Costa R; Sosa EA; Ramires JA
Arq Bras Cardiol; 2008 Feb; 90(2):138-43. PubMed ID: 18392387
[TBL] [Abstract][Full Text] [Related]
39. [Percutaneous coronary intervention combined cardiac resynchronization therapy for refractory heart failure secondary to ischemic cardiomyopathy].
Han YL; Zang HY; Wang DM; Jing QM; Wang SL; Wang ZL
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Jan; 33(1):17-21. PubMed ID: 15924770
[TBL] [Abstract][Full Text] [Related]
40. Effect of right ventricular lead location on response to cardiac resynchronization therapy in patients with end-stage heart failure.
Haghjoo M; Bonakdar HR; Jorat MV; Fazelifar AF; Alizadeh A; Ojaghi-Haghjghi Z; Esmaielzadeh M; Sadr-Ameli MA
Europace; 2009 Mar; 11(3):356-63. PubMed ID: 19136489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
